Skip to search formSkip to main contentSkip to account menu

21-hydroxy-6,19-oxidoprogesterone

Known as: 21-hydroxy-6,19-epoxyprogesterone, 21OH-6,19OP, 21OH-6OP 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Progesterone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
21-hydroxy-6,19-epoxyprogesterone: a Promising Therapeutic Agent and a Molecular Tool for Deciphering Glucocorticoid Action.
Glucocorticoids are steroid hormones that exert most of their effects through their binding to the glucocorticoid receptor (GR… 
2008
2008
Exploring the molecular basis of action of the passive antiglucocorticoid 21-hydroxy-6,19-epoxyprogesterone.
21-Hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a selective antiglucocorticoid that lacks the bulky substituent at C-11 found… 
2008
2008
Hemisuccinate of 21‐Hydroxy‐6,19‐Epoxyprogesterone: A Tissue‐Specific Modulator of the Glucocorticoid Receptor
The introduction of a hemisuccinate group at the 21‐position of the passive antiglucocorticoid 21OH‐6,19OP leads to a compound… 
2001
2001
A process for preparing 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP)
2001
2001
A process for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP)
1998
1998
21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) as medicament for treating glucocorticoid excess.
1998
1998
21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) its use as a medicament in the treatment of glucocorticoid excess
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)